BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15279667)

  • 1. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K; Fukuda T; Makino S; Harada M
    Clin Lab Haematol; 2004 Aug; 26(4):291-3. PubMed ID: 15279667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.
    Hequet O; Salles G; Ketterer N; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Bouafia F; Coiffier B
    Bone Marrow Transplant; 2003 Jul; 32(1):89-95. PubMed ID: 12815483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation.
    Imamura R; Inoue H; Kato K; Kobayashi S; Tsukamoto H; Nagafuji K; Shimoda K; Nakashima H; Otsuka T; Gondo H; Harada M
    Bone Marrow Transplant; 2002 Oct; 30(8):527-9. PubMed ID: 12379893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset of evans syndrome following autologous peripheral blood progenitor cell transplantation in a child.
    Gonzalez-Vicent M; Diaz MA; Garcia-Sanchez F; Molina J; Madero L
    Haematologica; 2002 May; 87(5):ECR17. PubMed ID: 12010680
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation.
    Urban C; Lackner H; Sovinz P; Benesch M; Schwinger W; Dornbusch HJ; Moser A
    Eur J Haematol; 2006 Jun; 76(6):526-30. PubMed ID: 16529601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    Motomura S; Hashimoto C; Kodama F; Maruta A; Sakai R; Fujita H; Tomita N; Fujisawa S; Harano H; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease.
    Keung YK; Cobos E; Bolanos-Meade J; Issarachai S; Brideau A; Morgan D
    Bone Marrow Transplant; 1997 Dec; 20(12):1099-101. PubMed ID: 9466285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-clore chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) for patients with malignant lymphoma--its role in the treatment strategy for non-Hodgkin's lymphoma, and ESHAP + PBSCT therapy].
    Tanosaki R; Okamoto S
    Rinsho Ketsueki; 1996 Jul; 37(7):591-7. PubMed ID: 8779778
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
    Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ
    Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation.
    Cordoba R; Arranz R; Cannata J
    Bone Marrow Transplant; 2005 Jun; 35(12):1217-8. PubMed ID: 15852026
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.
    Mabed M; Al-Kgodary T
    Bone Marrow Transplant; 2006 Apr; 37(8):739-43. PubMed ID: 16501587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Takeuchi M; Tamaoki A; Tada A; Jyo Y; Nomura S; Takahashi K; Ohsawa G; Kibata M
    Bone Marrow Transplant; 1998 Oct; 22(7):725-7. PubMed ID: 9818704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study.
    Choi SJ; Ryoo BY; Lee SS; Park Y; Kim BS; Kang YK
    Haematologica; 2002 May; 87(5):555-7. PubMed ID: 12010675
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
    Wadhwa PD; Fu P; Koc ON; Cooper BW; Fox RM; Creger RJ; Bajor DL; Bedi T; Laughlin MJ; Payne J; Gerson SL; Lazarus HM
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):13-22. PubMed ID: 15625540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation.
    Demirer T; Celebi H; Arat M; Ustün C; Demirer S; Dilek I; Ozcan M; Ilhan O; Akan H; Gürman G; Koç H
    Bone Marrow Transplant; 1999 Aug; 24(3):335-7. PubMed ID: 10455376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune thrombocytopenia following syngeneic peripheral blood stem cell transplantation].
    Nishio M; Sawada K; Koizumi K; Endoh T; Takashima H; Hashimoto H; Haseyama Y; Katagiri E; Fukada Y; Takano H; Tarumi T; Yasukouchi T; Koike T
    Rinsho Ketsueki; 1998 Aug; 39(8):580-5. PubMed ID: 9785976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma.
    Ohno E; Ohtsuka E; Iwashita T; Uno N; Ogata M; Kikuchi H; Nasu M
    Bone Marrow Transplant; 1997 May; 19(10):1045-7. PubMed ID: 9169652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.